Insider Transactions in Q1 2021 at Karuna Therapeutics, Inc. (KRTX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2021
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
5,000
-9.9%
|
$590,000
$118.48 P/Share
|
|
Mar 10
2021
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.01%
|
$45,000
$9.2 P/Share
|
|
Mar 08
2021
|
Heather Preston Director |
BUY
Other acquisition or disposition
|
Direct |
572
+8.24%
|
-
|
|
Mar 01
2021
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$312,500
$125.43 P/Share
|
|
Mar 01
2021
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$40,000
$16.0 P/Share
|
|
Feb 16
2021
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-43.48%
|
$1,190,000
$119.57 P/Share
|
|
Feb 16
2021
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+30.3%
|
$90,000
$9.2 P/Share
|
|
Feb 10
2021
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
5,000
-9.9%
|
$570,000
$114.06 P/Share
|
|
Feb 10
2021
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.01%
|
$45,000
$9.2 P/Share
|
|
Feb 09
2021
|
Pure Tech Health LLC |
SELL
Open market or private sale
|
Direct |
1,000,000
-29.36%
|
$118,000,000
$118.0 P/Share
|
|
Feb 01
2021
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$250,000
$100.0 P/Share
|
|
Feb 01
2021
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$40,000
$16.0 P/Share
|
|
Jan 11
2021
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
5,000
-5.16%
|
$525,000
$105.11 P/Share
|
|
Jan 11
2021
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.87%
|
$40,000
$8.24 P/Share
|
|
Jan 08
2021
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,000
-38.1%
|
$832,000
$104.49 P/Share
|
|
Jan 08
2021
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+27.59%
|
$72,000
$9.2 P/Share
|
|
Jan 08
2021
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
1,264
+33.33%
|
-
|
|
Jan 08
2021
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
150,000
-4.67%
|
-
|
|
Jan 08
2021
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
1,756
+33.33%
|
-
|
|
Jan 08
2021
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
150,000
-4.67%
|
-
|